Sign in
CompletedPhase 4

Multicenter study on patient’s ability to independently and safely use of Sildenafil 100 mg for erectile dysfunction.

Key facts

Who runs it
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
Where
Poland8 sites in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 4
People taking part
200 people enrolled
Started
17 Feb 2026
Ended
14 Apr 2026
Type of study
Interventional
Record updated
23 March 2026

Who can take part

Age
18 years and older
Sex
Men only
Healthy volunteers
Cannot take part
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • Males aged 18 years* and older sexually active and planning to have sexual interactions
  • Signed informed consent to participate in the study prior to commencing study procedures
  • Participants able to understand and follow study procedures

Who cannot take part

  • Symptoms of active infection
  • Severe physical or mental disease that might hamper the realization of the trial according to the protocol
  • Lack of reading and writing skills or comprehension in Polish
  • Unreliability or lack of cooperation

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The primary objective of the study is to assess whether participants using dedicated diagnostic tool can independently make safe decision whether it is appropriate for them to use or not use sildenafil in dose of 100 mg.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
A multicenter, prospective clinical TRrial evaluating patient’s ability to make an independent and safe decision regarding the USe of the medicinal product Sildenafil Polpharma100 mg indicated in the Treatment of erectile dysfunction. TRUST Trial on Responsible Use and Self-assessed Treatment.
Record updated
23 March 2026